Monte Rosa Therapeutics Ratios (2023-2025) | GLUE

Ratios Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin -2,996.71%-640.21%-258.12%25.72%56.17%-47.84%-236.98%
EBIT Margin -3,284.49%-695.25%-287.84%21.44%51.85%-67.06%-258.26%
EBITDA Margin -3,001.60%-645.09%-255.11%20.45%55.24%-53.20%-211.11%
Operating Margin -3,284.49%-695.25%-287.84%21.44%51.85%-67.06%-258.26%
Net Margin -3,006.11%-645.58%-258.89%22.11%55.20%-53.01%-212.10%
FCF Margin -3,717.01%-634.48%-232.13%212.28%-55.43%-157.00%781.46%
Efficiency
Assets Average 293.82M265.36M277.93M285.25M305.43M329.60M376.91M415.97M376.39M409.71M
Equity Average 228.69M199.09M181.89M165.88M188.59M215.06M214.20M249.05M271.62M256.96M
Invested Capital 243.73M213.65M184.52M179.25M152.52M224.67M205.46M222.94M275.16M268.08M245.84M
Asset Utilization Ratio 0.200.380.470.44
Leverage & Solvency
Equity Ratio 0.790.770.730.590.570.650.650.510.700.750.53
Valuation
Enterprise Value 331.70M291.25M178.81M46.54M253.83M80.07M199.70M45.41M-49.68M-23.45M56.01M
Market Capitalization 384.51M338.28M237.87M282.96M353.59M188.91M325.28M426.37M285.41M277.41M457.64M
Return Ratios
Return on Sales -0.96%0.04%0.14%0.12%
Return on Capital Employed -0.62%-0.59%-0.53%-0.45%-0.37%-0.01%0.04%0.02%
Return on Invested Capital -0.01%0.05%0.03%
Return on Assets -0.49%-0.47%-0.43%-0.36%-0.19%0.01%0.06%0.05%
Return on Equity -0.74%-0.82%-0.69%-0.56%-0.34%0.02%0.09%0.08%